Michael Mitter
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Michael Mitter has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
- Daniel Wolfram Gerlich
Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna BioCenter (VBC), Vienna, Austria
9 shared publications - Zsuzsanna Takacs
Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna BioCenter (VBC), Vienna, Austria
7 shared publications Delphine Theodorou
Basel Branch Diabetes Care, Roche Diagnostics International Ltd, Basel, Switzerland
5 shared publicationsJosip Zivkovic
MySugr GmbH, Vienna, Austria
4 shared publications- Thomas L. Steinacker
Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna Biocenter (VBC), Dr. Bohr-Gasse 3, Vienna, Austria
4 shared publications - Anton Goloborodko
Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA)
3 shared publications
Latest Publications
- 3 September 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 393 (6815)
Conformational asymmetry of replicated human chromosomes
DNA replication generates sister chromatids with identical sequence, yet its mechanism is fundamentally asymmetric: Chromatids inherit strands of opposite orientation, whereas forks synthesize new strands by distinct leading- and lagging-strand mechanisms. How this replication asymmetry affects chromosome organization is unknown. Using sister chromatid–sensitive conformation analysis, we found that human sister chromatids are consistently misaligned in the 5′→3′ direction of inherited DNA strands. This shift persisted without cohesin-mediated loop extrusion but was lost upon disruption of cohesion. Polymer modeling showed that modest directional misalignment of cohesive cohesins can explain the observed shift, and we propose two models for how such misalignment could originate from replication fork asymmetry. This register shift between sister chromatids has implications for homology search during DNA repair.
- 3 September 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 393 (6815)
Conformational asymmetry of replicated human chromosomes
DNA replication generates sister chromatids with identical sequence, yet its mechanism is fundamentally asymmetric: Chromatids inherit strands of opposite orientation, whereas forks synthesize new strands by distinct leading- and lagging-strand mechanisms. How this replication asymmetry affects chromosome organization is unknown. Using sister chromatid–sensitive conformation analysis, we found that human sister chromatids are consistently misaligned in the 5′→3′ direction of inherited DNA strands. This shift persisted without cohesin-mediated loop extrusion but was lost upon disruption of cohesion. Polymer modeling showed that modest directional misalignment of cohesive cohesins can explain the observed shift, and we propose two models for how such misalignment could originate from replication fork asymmetry. This register shift between sister chromatids has implications for homology search during DNA repair.
- Open Access
- 15 June 2026
- Published by SAGE Publications in Diabetes Technology & Therapeutics
Increased Usage of a Diabetes Management App Was Associated with Significant Improvement in Both Glycemic and Non-Glycemic Outcomes for People with Diabetes
Introduction: Mobile health applications (apps) have been associated with improved glycemic outcomes in people with diabetes, but the behavioral factors leading to these outcomes remain poorly understood. The aim of this study was to quantify the impact of a diabetes app (mySugr ® ) on glycemic and non-glycemic outcomes and to explore the relationship between behavior and glycemic control by investigating app usage patterns. Methods: Glycemic (blood glucose [BG]) and non-glycemic (body mass index [BMI] and “tags” indicating hypoglycemia and hyperglycemia feelings) outcomes of mySugr users with type 1 (T1DM) or type 2 (T2DM) diabetes mellitus were collected in the app over 90 days and assessed through population analysis, including stratification by frequency of app usage. Linear modeling was employed to identify characteristics of app users that may predict glycemic outcomes. Results: Data from 80,044 mySugr users were analyzed. Improved glycemic control was observed (change in mean BG = −12.5 mg/dL; P < 0.001), correlating with app usage and was greatest in users with >16 app sessions/day. In users with T2DM, a 2.4% reduction from baseline was observed in mean BMI (−0.76 kg/m 2 ; P < 0.001; n = 6910). Users with T1DM or T2DM reported reductions of 16% and 27% in hypoglycemia and hyperglycemia feelings, respectively (143,600 tags). Linear models showed a significant fit ( P < 0.001) for both T1DM ( n = 17,465) and T2DM ( n = 39,069) users and explained a large degree of the variability in glycemic outcomes ( R 2 = 0.355 for T1DM and R 2 = 0.444 for T2DM). Baseline glycemic control was the strongest predictor of glycemic outcomes, followed by number of BG logs and app engagement. Conclusions: Using a digital diabetes app can improve glycemic and non-glycemic outcomes in people with diabetes. This work also establishes a methodology to correlate user behavior with glycemic control.
- 15 June 2026
- Published by SAGE Publications in Diabetes Technology & Therapeutics
Open AccessIncreased Usage of a Diabetes Management App Was Associated with Significant Improvement in Both Glycemic and Non-Glycemic Outcomes for People with Diabetes
Introduction: Mobile health applications (apps) have been associated with improved glycemic outcomes in people with diabetes, but the behavioral factors leading to these outcomes remain poorly understood. The aim of this study was to quantify the impact of a diabetes app (mySugr ® ) on glycemic and non-glycemic outcomes and to explore the relationship between behavior and glycemic control by investigating app usage patterns. Methods: Glycemic (blood glucose [BG]) and non-glycemic (body mass index [BMI] and “tags” indicating hypoglycemia and hyperglycemia feelings) outcomes of mySugr users with type 1 (T1DM) or type 2 (T2DM) diabetes mellitus were collected in the app over 90 days and assessed through population analysis, including stratification by frequency of app usage. Linear modeling was employed to identify characteristics of app users that may predict glycemic outcomes. Results: Data from 80,044 mySugr users were analyzed. Improved glycemic control was observed (change in mean BG = −12.5 mg/dL; P < 0.001), correlating with app usage and was greatest in users with >16 app sessions/day. In users with T2DM, a 2.4% reduction from baseline was observed in mean BMI (−0.76 kg/m 2 ; P < 0.001; n = 6910). Users with T1DM or T2DM reported reductions of 16% and 27% in hypoglycemia and hyperglycemia feelings, respectively (143,600 tags). Linear models showed a significant fit ( P < 0.001) for both T1DM ( n = 17,465) and T2DM ( n = 39,069) users and explained a large degree of the variability in glycemic outcomes ( R 2 = 0.355 for T1DM and R 2 = 0.444 for T2DM). Baseline glycemic control was the strongest predictor of glycemic outcomes, followed by number of BG logs and app engagement. Conclusions: Using a digital diabetes app can improve glycemic and non-glycemic outcomes in people with diabetes. This work also establishes a methodology to correlate user behavior with glycemic control.
- Open Access
Digital biomarkers for insulin resistance screening in daily life
One in four adults has insulin resistance (IR), a modifiable driver of type-2 diabetes that can precede diagnosis by a decade. However, IR assessment remains clinic- and laboratory-based, limiting repeated population screening. We tested whether free-living wearable data can detect IR in adults with normoglycemia or prediabetes. Machine-learning models using continuous glucose monitor(CGM)-based glucose dynamics and smartwatch-based heart rate/heart rate variability were developed in Study 1 ( N = 97) and externally validated without retraining in Study 2 ( N = 61, 31% IR prevalence). The best-performing CGM-based model achieved AU-ROC = 0.873 [0.756–0.967] and AU-PRC = 0.816 [0.640–0.934], outperforming an anthropometrics-only baseline (AU-ROC = 0.749, AU-PRC = 0.593). Findings are the first to detect IR from wearables without blood tests or structured glucose challenges, with state-of-the-art comparable performance. By enabling continuous at-home screening, this approach can identify undetected at-risk individuals and trigger confirmatory blood tests to close detection gaps.
Open AccessDigital biomarkers for insulin resistance screening in daily life
One in four adults has insulin resistance (IR), a modifiable driver of type-2 diabetes that can precede diagnosis by a decade. However, IR assessment remains clinic- and laboratory-based, limiting repeated population screening. We tested whether free-living wearable data can detect IR in adults with normoglycemia or prediabetes. Machine-learning models using continuous glucose monitor(CGM)-based glucose dynamics and smartwatch-based heart rate/heart rate variability were developed in Study 1 ( N = 97) and externally validated without retraining in Study 2 ( N = 61, 31% IR prevalence). The best-performing CGM-based model achieved AU-ROC = 0.873 [0.756–0.967] and AU-PRC = 0.816 [0.640–0.934], outperforming an anthropometrics-only baseline (AU-ROC = 0.749, AU-PRC = 0.593). Findings are the first to detect IR from wearables without blood tests or structured glucose challenges, with state-of-the-art comparable performance. By enabling continuous at-home screening, this approach can identify undetected at-risk individuals and trigger confirmatory blood tests to close detection gaps.
- Open Access
- 23 March 2026
- Published by SAGE Publications in Diabetes Technology and Obesity Medicine
- Vol. 2
Manual Logging of Blood Glucose Data to a Digital Logbook: Real-World Impact of a Standalone Digital Diabetes App on Blood Glucose Management over Six Months
Introduction: Digital diabetes apps are associated with improved glycemic control in people with type 1 (T1D) and type 2 (T2D) diabetes mellitus. In this retrospective, real-world data study, we aimed to assess the standalone effect of the mySugr app on glycemic control, without the use of additional connected devices to monitor/manage diabetes therapy. Methods: Data were collected from mySugr Logbook users who registered from January 2018 to July 2025 and provided consent for personal data processing. Eligible users were ≥16 years old upon registration, did not have imported blood glucose (BG) log entries from connected devices, and had manually logged BG for a minimum of two entries per day for 14 days per month, for the first 6 months of logbook use. Mean monthly BG, coefficient of variation (CV), and proportions of tests below (180 mg/dL) were calculated for each user. Mean values for each metric were calculated across users and compared across 6 months of mySugr use. Paired samples t-tests with Bonferroni corrections were performed. Results: Of the 11,891 users in the sample population, 3523 (29.6%) were people with T1D, 6704 (56.4%) were people with T2D, and 1664 (14.0%) had other/non-disclosed diabetes types. Mean (standard error of measurement [SEM]) monthly BG and CV significantly decreased from the first to the sixth month of mySugr Logbook use (Δ = –6.69 [±0.25] mg/dL and Δ = –1.70 [±0.06]%, respectively; both P < 0.001). Mean (SEM) monthly proportion of tests in range significantly increased (Δ = 4.05 [±0.15]%; P < 0.001). Conclusions: Highly engaged mySugr Logbook users, who manually logged their BG values without any automatically imported BG data, improved their glycemic outcomes over 6 months, suggesting that the mySugr Logbook may facilitate therapy adherence and constructive lifestyle adjustments.
- 23 March 2026
- Published by SAGE Publications in Diabetes Technology and Obesity Medicine
- Vol. 2
Open AccessManual Logging of Blood Glucose Data to a Digital Logbook: Real-World Impact of a Standalone Digital Diabetes App on Blood Glucose Management over Six Months
Introduction: Digital diabetes apps are associated with improved glycemic control in people with type 1 (T1D) and type 2 (T2D) diabetes mellitus. In this retrospective, real-world data study, we aimed to assess the standalone effect of the mySugr app on glycemic control, without the use of additional connected devices to monitor/manage diabetes therapy. Methods: Data were collected from mySugr Logbook users who registered from January 2018 to July 2025 and provided consent for personal data processing. Eligible users were ≥16 years old upon registration, did not have imported blood glucose (BG) log entries from connected devices, and had manually logged BG for a minimum of two entries per day for 14 days per month, for the first 6 months of logbook use. Mean monthly BG, coefficient of variation (CV), and proportions of tests below (180 mg/dL) were calculated for each user. Mean values for each metric were calculated across users and compared across 6 months of mySugr use. Paired samples t-tests with Bonferroni corrections were performed. Results: Of the 11,891 users in the sample population, 3523 (29.6%) were people with T1D, 6704 (56.4%) were people with T2D, and 1664 (14.0%) had other/non-disclosed diabetes types. Mean (standard error of measurement [SEM]) monthly BG and CV significantly decreased from the first to the sixth month of mySugr Logbook use (Δ = –6.69 [±0.25] mg/dL and Δ = –1.70 [±0.06]%, respectively; both P < 0.001). Mean (SEM) monthly proportion of tests in range significantly increased (Δ = 4.05 [±0.15]%; P < 0.001). Conclusions: Highly engaged mySugr Logbook users, who manually logged their BG values without any automatically imported BG data, improved their glycemic outcomes over 6 months, suggesting that the mySugr Logbook may facilitate therapy adherence and constructive lifestyle adjustments.
- Open Access
- 24 February 2026
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 234, 113188
Control of nocturnal hypoglycemia by CGM-based AI-enabled nocturnal hypoglycemia prediction: A retrospective analysis of real-world data
- 24 February 2026
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 234, 113188
Open AccessControl of nocturnal hypoglycemia by CGM-based AI-enabled nocturnal hypoglycemia prediction: A retrospective analysis of real-world data
- Open Access
- 13 February 2026
- Published by Springer Nature in Diabetologia
- Vol. 69 (6) , 1457-1467
Exercise in type 1 diabetes: real-world data on glucose levels and hypoglycaemia risk from over 420,000 exercise sessions
Aims/hypothesis: This large observational cohort real-world study explored the effects of three forms of exercise (walking [WALK], aerobic excluding walking [AER] and anaerobic [ANAER]) on glucose levels and hypoglycaemia risk in type 1 diabetes. Methods: Data were collected from 3248 users of mySugr Logbook and Apple Health (mean ± SD age 41.23±12.25 years; glucose management index of 7.05±1.09%; 41.5% were female) over a total of 428,058 exercise sessions. Acute and 24 h glycaemic effects were examined across exercise types. Post-exercise glycaemia data over 24 h were compared with sedentary glycaemic data. Time of exercise was used to assess the probability of nocturnal hypoglycaemia. Results: Independent of type, exercise decreased glucose by −1.06±0.89 mmol/l. For the individual types of exercise, WALK decreased levels by −1.24±0.81 mmol/l, AER by −1.43±1.02 mmol/l and ANAER by −0.52±0.81 mmol/l (all p p p p <0.01). Conclusions/interpretation: Aerobic activities decreased glucose more during exercise sessions than anaerobic exercise and yielded larger acute hypoglycaemia risk; anaerobic activities yielded the largest 24 h glycaemic improvements. More-intense exercise resulted in a larger nocturnal hypoglycaemia than walking; exercise timing was not a relevant contributor to nocturnal hypoglycaemia. Graphical
- 13 February 2026
- Published by Springer Nature in Diabetologia
- Vol. 69 (6) , 1457-1467
Open AccessExercise in type 1 diabetes: real-world data on glucose levels and hypoglycaemia risk from over 420,000 exercise sessions
Aims/hypothesis: This large observational cohort real-world study explored the effects of three forms of exercise (walking [WALK], aerobic excluding walking [AER] and anaerobic [ANAER]) on glucose levels and hypoglycaemia risk in type 1 diabetes. Methods: Data were collected from 3248 users of mySugr Logbook and Apple Health (mean ± SD age 41.23±12.25 years; glucose management index of 7.05±1.09%; 41.5% were female) over a total of 428,058 exercise sessions. Acute and 24 h glycaemic effects were examined across exercise types. Post-exercise glycaemia data over 24 h were compared with sedentary glycaemic data. Time of exercise was used to assess the probability of nocturnal hypoglycaemia. Results: Independent of type, exercise decreased glucose by −1.06±0.89 mmol/l. For the individual types of exercise, WALK decreased levels by −1.24±0.81 mmol/l, AER by −1.43±1.02 mmol/l and ANAER by −0.52±0.81 mmol/l (all p p p p <0.01). Conclusions/interpretation: Aerobic activities decreased glucose more during exercise sessions than anaerobic exercise and yielded larger acute hypoglycaemia risk; anaerobic activities yielded the largest 24 h glycaemic improvements. More-intense exercise resulted in a larger nocturnal hypoglycaemia than walking; exercise timing was not a relevant contributor to nocturnal hypoglycaemia. Graphical
- 23 January 2026
- Published by SAGE Publications in Diabetes Technology & Therapeutics
- Vol. 28 (7) , 757
Response to Comment on: “Nocturnal Hypoglycemia: Characterization with Continuous Glucose Monitoring in a Real-World Setting”
- 23 January 2026
- Published by SAGE Publications in Diabetes Technology & Therapeutics
- Vol. 28 (7) , 757
Response to Comment on: “Nocturnal Hypoglycemia: Characterization with Continuous Glucose Monitoring in a Real-World Setting”
- 4 December 2025
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 390 (6777) , eadw0566
Cohesin guides homology search during DNA repair using loops and sister chromatid linkages
Accurate repair of DNA double-strand breaks (DSBs) is essential for genome stability, and defective repair underlies diseases such as cancer. Homologous recombination uses an intact homologous sequence to faithfully restore damaged DNA, yet how broken DNA ends find homologous sites in a genome containing billions of bases remains unclear. Here, we introduce sister-pore-C, a high-resolution method to map intra- and intermolecular interactions in replicated chromosomes. We show how DSBs remodel chromosome architecture using two functionally distinct pools of cohesin. Loop-extruding cohesin accumulates across megabase-scale domains surrounding DSBs to control local homology sampling, whereas cohesive cohesin concentrates at break sites to tether DNA ends to the sister chromatid. This mechanism restricts the homology-sampling space, highlighting how chromosome conformation helps to preserve genomic integrity.
- 4 December 2025
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 390 (6777) , eadw0566
Cohesin guides homology search during DNA repair using loops and sister chromatid linkages
Accurate repair of DNA double-strand breaks (DSBs) is essential for genome stability, and defective repair underlies diseases such as cancer. Homologous recombination uses an intact homologous sequence to faithfully restore damaged DNA, yet how broken DNA ends find homologous sites in a genome containing billions of bases remains unclear. Here, we introduce sister-pore-C, a high-resolution method to map intra- and intermolecular interactions in replicated chromosomes. We show how DSBs remodel chromosome architecture using two functionally distinct pools of cohesin. Loop-extruding cohesin accumulates across megabase-scale domains surrounding DSBs to control local homology sampling, whereas cohesive cohesin concentrates at break sites to tether DNA ends to the sister chromatid. This mechanism restricts the homology-sampling space, highlighting how chromosome conformation helps to preserve genomic integrity.
- Open Access
- 1 November 2025
- Published by SAGE Publications in Diabetes Technology & Therapeutics
- Vol. 27 (11) , 890-898
Nocturnal Hypoglycemia: Characterization with Continuous Glucose Monitoring in a Real-World Setting
Background: Nocturnal hypoglycemia is a common complication in people with diabetes. The use of continuous glucose monitoring (CGM) has reduced the frequency of hypoglycemia and improved its clinical characterization; however, available CGM data mostly focus on overall or diurnal hypoglycemia in people with type 1 diabetes (T1D). This real-world study compared the frequency and duration of nocturnal versus diurnal hypoglycemia in people with T1D or type 2 diabetes (T2D) and evaluated the subsequent impact of nocturnal hypoglycemia on daytime glucose profiles. Methods: Between January 2010 and September 2023, CGM data during the first month of use were collected retrospectively from people with T1D ( n = 3696) or T2D ( n = 441) using multiple daily insulin injections. Hypoglycemic events were identified as CGM readings: P < 0.001). Similar trends were observed in T2D, with nocturnal hypoglycemia events lasting 57 min versus 40 min diurnally ( P < 0.001). Significant changes in multiple glycemic parameters were observed during days following nocturnal hypoglycemic events versus days following nights without hypoglycemia. These findings suggest a heightened risk of morning hypoglycemia following nocturnal hypoglycemia. Conclusion: These results showed that nocturnal hypoglycemia is characterized by longer duration and slower recovery than daytime hypoglycemia, with significant effects on next-day glycemic control, which emphasizes the need for improved prevention strategies.
- 1 November 2025
- Published by SAGE Publications in Diabetes Technology & Therapeutics
- Vol. 27 (11) , 890-898
Open AccessNocturnal Hypoglycemia: Characterization with Continuous Glucose Monitoring in a Real-World Setting
Background: Nocturnal hypoglycemia is a common complication in people with diabetes. The use of continuous glucose monitoring (CGM) has reduced the frequency of hypoglycemia and improved its clinical characterization; however, available CGM data mostly focus on overall or diurnal hypoglycemia in people with type 1 diabetes (T1D). This real-world study compared the frequency and duration of nocturnal versus diurnal hypoglycemia in people with T1D or type 2 diabetes (T2D) and evaluated the subsequent impact of nocturnal hypoglycemia on daytime glucose profiles. Methods: Between January 2010 and September 2023, CGM data during the first month of use were collected retrospectively from people with T1D ( n = 3696) or T2D ( n = 441) using multiple daily insulin injections. Hypoglycemic events were identified as CGM readings: P < 0.001). Similar trends were observed in T2D, with nocturnal hypoglycemia events lasting 57 min versus 40 min diurnally ( P < 0.001). Significant changes in multiple glycemic parameters were observed during days following nocturnal hypoglycemic events versus days following nights without hypoglycemia. These findings suggest a heightened risk of morning hypoglycemia following nocturnal hypoglycemia. Conclusion: These results showed that nocturnal hypoglycemia is characterized by longer duration and slower recovery than daytime hypoglycemia, with significant effects on next-day glycemic control, which emphasizes the need for improved prevention strategies.
- Open Access
Conformational asymmetry of replicated human chromosomes
DNA replication creates two sister chromatids that must acquire specific three-dimensional conformations to support genome function and stability. This organization is largely mediated by cohesin complexes, which extrude intra-chromosomal loops and link two chromatids, thus forming “chromatid cohesion”. Although sister chromatids are genetically identical, the replication process is intrinsically asymmetric: each chromatid inherits a different parental DNA strand, while the new strands are synthesized using distinct “leading” and “lagging” mechanisms of the replication fork. Whether and how this molecular asymmetry impacts higher-order chromatin organization remains unknown. Using sister-chromatid-sensitive Hi-C, strand-specific FISH, and polymer modeling, we reveal a consistent, genome-wide shift in sister chromatid alignment, biased along the 5′-3′ direction of the inherited strands. This shift persists without loop extrusion but is lost upon disruption of cohesion, implicating cohesive cohesins in maintaining the displacement. Polymer simulations indicate that a modest (∼100 kb) misalignment of “cohesive” cohesins is responsible for the observed asymmetry. We propose two mechanistic models that explain how this displacement arises from replication fork asymmetry: either through the dislocation of cohesin during replication or through the asymmetric anchoring and subsequent random sliding of cohesin pairs. These findings reveal a previously unrecognized chromosome-scale asymmetry in sister chromatid organization, which has implications for homology search during DNA repair.
Open AccessConformational asymmetry of replicated human chromosomes
DNA replication creates two sister chromatids that must acquire specific three-dimensional conformations to support genome function and stability. This organization is largely mediated by cohesin complexes, which extrude intra-chromosomal loops and link two chromatids, thus forming “chromatid cohesion”. Although sister chromatids are genetically identical, the replication process is intrinsically asymmetric: each chromatid inherits a different parental DNA strand, while the new strands are synthesized using distinct “leading” and “lagging” mechanisms of the replication fork. Whether and how this molecular asymmetry impacts higher-order chromatin organization remains unknown. Using sister-chromatid-sensitive Hi-C, strand-specific FISH, and polymer modeling, we reveal a consistent, genome-wide shift in sister chromatid alignment, biased along the 5′-3′ direction of the inherited strands. This shift persists without loop extrusion but is lost upon disruption of cohesion, implicating cohesive cohesins in maintaining the displacement. Polymer simulations indicate that a modest (∼100 kb) misalignment of “cohesive” cohesins is responsible for the observed asymmetry. We propose two mechanistic models that explain how this displacement arises from replication fork asymmetry: either through the dislocation of cohesin during replication or through the asymmetric anchoring and subsequent random sliding of cohesin pairs. These findings reveal a previously unrecognized chromosome-scale asymmetry in sister chromatid organization, which has implications for homology search during DNA repair.